Clinical Trial Update: Reduce Immunosuppression With Atmp in NS ChildrEn [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating ATMP to reduce immunosuppression in children with steroid-dependent nephrotic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Nephrotic Syndrome
• Nephrotic Syndrome in Children
• Steroid-dependent Nephrotic Syndrome

Drugs mentioned

• ATMP

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Nephrotic Syndrome in Children, Steroid-Dependent Nephrotic Syndrome | Phase 2 | Status: COMPLETED